XSWX
STMN
Market cap1.74bUSD
, Last price
CHF
Name
Straumann Holding AG
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Straumann Holding AG is a global leader in providing advanced solutions for tooth replacement and orthodontic treatment. The company actively researches, develops, manufactures, and distributes a comprehensive range of dental products and services designed for tooth correction, restoration, replacement, and the prevention of tooth loss. Its extensive portfolio includes various dental implant systems (such as titanium, titanium alloy, ceramic, and mini implants), specialized surgical instruments, sophisticated CAD/CAM prosthetics, and the Clear Correct orthodontic aligners. Straumann also supplies vital biomaterials, including bone substitutes, membranes, and biologics, alongside cutting-edge digital tools like intraoral scanners, 3D printers, and milling machines for dental professionals and laboratories. Additionally, the company offers educational and training services to its customers. Straumann serves a diverse clientele, encompassing general dentists, specialists, dental technicians, laboratories, and institutional clients such as distributors, hospitals, and universities, reaching approximately 100 countries through its broad network of subsidiaries and partners. Established in 1954, Straumann Holding AG is headquartered in Basel, Switzerland.
Related entities
Subsidiaries
Institut Straumann AG
Key people
Petra Rumpf
Non-Executive Independent Chairman of the Board · since 2024
Non-Executive Independent Vice Chairman of the Board · since 2022
Arnoud Middel
Member of the Executive Board, Chief People Officer · since 2024
Thomas Friese
Member of the Executive Board, Chief Technology and Information Officer · since 2024
Grant Bester
Member of the Executive Board · since 2025
Alexei Costa
Member of the Executive Board Executive Vice President - Latin America and President Neodent · since 2025
Sara Dalmasso
Member of the Executive Board, Head of Straumann Group Enterprise Solutions · since 2023
Guillaume Daniellot
Chief Executive Officer, Member of the Executive Management Board · since 2020
Holger Haderer
Member of the Executive Management Board, Regional Head Europe, Middle East & Africa · since 2024
Florian Kirsch
Member of the Executive Management Board, Head of Connected Customer Solutions and Orthodontics Business Unit · since 2023
Patrick Loh
Member of the Executive Management Board, Regional Head Asia Pacific · since 2022
Sebastien Roche
Member of the Executive Management Board, Chief Operations Officer · since 2022
Andreas Utz
Member of the Executive Management Board, Head Implantology Business Unit · since 2024
Xiaoqun Clever-Steg
Non-Executive Independent Director · since 2024
Olivier Filliol
Non-Executive Independent Director · since 2023
Non-Executive Independent Director · since 2022
Stefan Meister
Non-Executive Independent Director · since 2024
Non-Executive Independent Director · since 2017
IPO date
Jun 01, 1998
Employees
10,543
Domiciled in
CH
Incorporated in
CH
Headquarters & legal address
Peter Merian-Weg 12
Basel, BS 4002
CH
Basel, BS 4002
CH
Other language
Straumann Holding Ltd
Other language
Straumann Holding SA
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||